-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tabelecleucel in Epstein–Barr Virus (HHV-4) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tabelecleucel in Epstein–Barr Virus (HHV-4) Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tabelecleucel in Epstein–Barr Virus (HHV-4) Infections Drug Details: Tabelecleucel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tabelecleucel in Post-Transplant Lymphoproliferative Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tabelecleucel in Post-Transplant Lymphoproliferative Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tabelecleucel in Post-Transplant Lymphoproliferative Disorder Drug Details: Tabelecleucel (Ebvallo) is...
-
Product Insights
NewQuarterly Nuts & Seeds pricing trends in India
Empower your strategies with our Quarterly Nuts & Seeds pricing trends in India report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Sector Analysis
NewHER2-Positive Breast Cancer Epidemiology Analysis and Forecast to 2033
Reasons to buy the ‘HER2-Positive Breast Cancer Epidemiology’ market report: Get an overview of the HER2+ breast cancer risk factors, comorbidities, and global and historical epidemiological trends in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China). Get valuable insights into the 10-year epidemiology forecast for Diagnosed incident cases of all invasive breast cancer Diagnosed incident cases of HER2+ breast cancer Five diagnosed prevalent cases of HER2+ breast cancer Understand the diagnosed incident cases...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RiMO-401 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RiMO-401 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RiMO-401 in Head And Neck Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NX-210c in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NX-210c in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NX-210c in Alzheimer's Disease Drug Details: NX-210c is under development for...
-
Product Insights
NewQuarterly Breakfast Cereals pricing trends in the United Arab Emirates
Empower your strategies with our Quarterly Breakfast Cereals pricing trends in the United Arab Emirates report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewClearPoint Neuro Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ClearPoint Neuro Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ClearPoint Neuro Inc (ClearPoint) is a clinical gear organization. It creates and commercializes stages for carrying out intrusive surgeries. Its items incorporate ClearPoint framework a careful stage, that empowers conveyance of treatments treat a neurological infections and issues by giving continuous X-ray direction; SmartFlow Neuro Ventricular Cannula a X-ray Directed Medication Conveyance framework and TRANBERG Warm Treatment Framework. These...
-
Product Insights
NewDiamiR LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our DiamiR LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. DiamiR LLC (DiamiR) is a medical device company. The company is involved in the development and commercialization of technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis. It offers microRNAs that are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production. DiamiR...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AbGn-268 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AbGn-268 in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AbGn-268 in Ulcerative Colitis Drug Details: AbGn-168H2 (leiolizumab) is under development...